StreetAlpha.app
Home › Stocks › BIO

Bio-rad Laboratories, Inc. (BIO)

Healthcare
$358.90
▼ −2.34%
LAST CLOSE · NOV 20

Bio-Rad makes life science research tools and clinical diagnostic test systems for labs, hospitals and research institutions. It last closed at $358.90 on Nov 20, down 2.34% on the day. The next earnings report for BIO is expected around Thu, Feb 11, 2027, after the close. For the quarter ended Sep 2026, BIO reported EPS of $17.02 on revenue of $656.4M, with revenue up 0.5% from a year ago. Over its last 8 reports the stock moved an average of 7.7% the session after earnings.

AI Auto Pilots
Is BIO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BIO.

Key Stats

Last 12 months
Results
Revenue
$2.6B
+1.4% vs a year ago
Net income
$1.0B
39.5% margin
EPS (diluted)
$37.64
Free cash flow
$329.1M
12.7% margin
Balance sheet
Cash & equivalents
$465.3M
At Sep 30
Debt
$1.2B
At Sep 30
Shareholder equity
$7.6B
Buybacks
$79.3M
Last 12 months
Employees8,300 (Mar 16, 2023)
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $2.9B$2.9BFY2021FY2022: $2.8B$2.8BFY2022FY2023: $2.7B$2.7BFY2023FY2024: $2.6B$2.6BFY2024FY2025: $2.6B$2.6BFY2025

From BIO's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 11
Estimated date · After the close
Reported EPS
$17.02
Quarter ended Sep 2026
Year ago EPS
-$12.70
Same quarter last year
Revenue
$656.4M
+0.5% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$25.57Dec '24Mar 2025: $2.29Mar '25Jun 2025: $11.67Jun '25Sep 2025: -$12.70Sep '25Dec 2025: $26.39Dec '25Mar 2026: -$19.55Mar '26Jun 2026: $13.85Jun '26Sep 2026: $17.02Sep '26Latest $17.02
Revenue by quarter
Dec 2024: $667.5MDec '24Mar 2025: $585.4MMar '25Jun 2025: $651.6MJun '25Sep 2025: $653.0MSep '25Dec 2025: $693.2MDec '25Mar 2026: $592.1MMar '26Jun 2026: $651.0MJun '26Sep 2026: $656.4MSep '26Latest $656.4M
How BIO moved after its last 8 reports
Average move the session after a report ±7.7%
Nov 4, 2026After the close−2.9%
Aug 4, 2026After the close+4.5%
Apr 30, 2026After the close−8.4%
Feb 12, 2026After the close−12.3%
Oct 29, 2025After the close−4.7%
Jul 31, 2025After the close+17.6%
May 1, 2025After the close−1.7%
Feb 13, 2025After the close−9.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on BIOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on BIO
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on BIO

Technical Analysis

BIO · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend

The stock is 4% below its 20 day and 4% below its 50 day average. It is 11% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 43). The nearest support is the 100 day average at $357.00, and the nearest resistance the Pivot at $360.55.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 3.5%/day
Key levels
$396.2352 week high+10.4%
$373.9720 day average+4.2%
$371.6350 day average+3.5%
$367.79Pivot R1+2.5%
$365.00Swing high (Aug 13)+1.7%
$360.55Pivot+0.5%
$358.90Last close
$357.00100 day average−0.5%
$353.97Swing low (Oct 8)−1.4%
$351.66Pivot S1−2.0%
$318.59200 day average−11.2%
$236.7352 week low−34.0%
Indicators
RSI (14)42.90Middle of its rangeNeutral
MACD-1.73Below its signal lineBearish
Stochastic31.5Middle of its rangeNeutral
ADX (14)13.6No clear trend
Williams %R-84.0Oversold below −80, overbought above −20Oversold
CCI (20)-123.5Oversold below −100, overbought above 100Oversold
Rate of change−5.9%Change over 10 sessionsBearish
ATR (14)$12.70Typical daily range, 3.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for BIO

What happened before

See how BIO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow BIO usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How BIO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for BIOHow many large options trades hit BIO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

BIO Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●194 buying vs 171 selling
  • ▼Shares held by funds -14.7%
  • ▲Funds holding +18
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding419401+4.5%
In funds' top 1054+25.0%
Held by funds–––
New / increased63 / 13156 / 113+14.8%
Reduced / sold out132 / 39156 / 53−18.2%
Put/call ratio0.62––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BIO institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BIO is in one of them and how their past BIO trades turned out.

BIO in the AI portfolios
Loading…

BIO News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BIO in an article yet. Here's the latest on the wider market.

BIO in the news

BIO Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Oct 10
Who traded BIO · since 2015
Latest 5 filings of 15
$1K – $15KTraded Sep 8, 2023Filed Oct 10, 2023
$1K – $15KTraded Jun 29, 2023Filed Jul 28, 2023
$1K – $15KTraded Jun 28, 2023Filed Jul 28, 2023
$1K – $15KTraded Nov 30, 2022Filed Dec 29, 2022
$1K – $15KTraded Mar 30, 2022Filed Apr 8, 2022
PersonTypeAmountTradedFiledDelay
Lois FrankelD · FLSell$1K – $15KSep 8, 2023Oct 10, 202332 d
Lois FrankelD · FLBuy$1K – $15KJun 29, 2023Jul 28, 202329 d
Lois FrankelD · FLBuy$1K – $15KJun 28, 2023Jul 28, 202330 d
Susie LeeD · NVSell$1K – $15KNov 30, 2022Dec 29, 202229 d
Tommy TubervilleR · ALSell$1K – $15KMar 30, 2022Apr 8, 20229 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Bio-rad Laboratories

Bio-Rad is a life science and clinical diagnostics company based in Hercules, California. Its life science unit makes instruments, systems, reagents, and consumables used to separate, purify, and measure cells, proteins, and nucleic acids. Its diagnostics unit supplies test systems, software, test kits, and quality controls for the in vitro diagnostics market. Customers include universities, research institutions, pharmaceutical and biotechnology companies, hospital and reference laboratories, and food testing labs.

Headquarters
Hercules, CA
Founded
1952